6533b83afe1ef96bd12a7a0b

RESEARCH PRODUCT

Efficient synthesis of hexahydroindenopyridines and their potential as melatoninergic ligands.

Nuria CabedoAmelia DíazDiego CortesLaura MorenoNoureddine El AouadAbraham GalánMaria-jesus SanzBruno FigadèreDaniel-henri CaignardJavier Párraga

subject

StereochemistryPyridinesRing (chemistry)LigandsMelatonin receptorMethylenedioxyEnaminechemistry.chemical_compoundStructure-Activity RelationshipDrug DiscoveryHumansReceptorCells CulturedPharmacologychemistry.chemical_classificationBinding SitesDose-Response Relationship DrugMolecular StructureReceptor Melatonin MT2Receptor Melatonin MT1Organic ChemistryGeneral MedicineHEK293 CellschemistryPiperidineAcetamideTricyclic

description

Hexahydroindenopyridine (HHIP) is an interesting tricyclic piperidine nucleus that is structurally related to melatonin, a serotonin-derived neurohormone. Melatonin receptor ligands have applications in several cellular, neuroendocrine and neurophysiological disorders, including depression and/or insomnia. We report herein an efficient two-step method to prepare new HHIP via enamine C-alkylation-cyclization. The influence of substituents on the benzene ring and the nitrogen atom on melatoninergic receptors has been studied. Among the 25 synthesized HHIPs, some of them containing methylenedioxy (series 2) and 8-chloro-7-methoxy substituents (series 4) on the benzene ring revealed affinity for the MT1 and/or the MT2 receptors within the nanomolar range or low micromolar. Similar activities were also encountered for those presenting urea (4g), N-aryl (2e) and N-alkyl (2f) acetamide functions. Therefore, new synthesized compounds with a HHIP nucleus have emerged as new promising leads towards the discovery of melatoninergic ligands which could provide new therapeutic agents.

10.1016/j.ejmech.2014.09.038https://pubmed.ncbi.nlm.nih.gov/25232966